Diagnostic Lab Requisition Volume Growth measures year-over-year growth in Quest Diagnostics test requisitions, including acquired volume.
Quest Diagnostics reported 12.3% requisition-volume growth in 2025.
Reported growth exceeded organic growth by 8.9 percentage points
Quest reported 3.4% organic requisition-volume growth.
Subtracting 3.4% from 12.3% gives an 8.9-point gap, showing that acquisition and scope effects materially amplified reported volume.
Organic growth was only about 27.6% of the reported rate
The ratio of 3.4% to 12.3% is approximately 27.6%.
That is a scale comparison, not a formal attribution of incremental requisitions.
Use Diagnostic Lab Organic Requisition Volume Growth to keep the underlying-growth measure separate.
Reported volume growth is not same-store growth
Quest's figure includes acquired requisitions.
It should not be interpreted as a pure read on demand from the pre-existing laboratory network.
Primary source: Quest Diagnostics 2025 Form 10-K.
Part of the Diagnostic Laboratory Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- DGXOpen operating-model research →17 of 17 reviewed concepts in Diagnostic Laboratory EconomicsRequisition growth and monetization6 of 6 bridge concepts supportedContinue through this bridge:Diagnostic Information Services RevenueDiagnostic Lab Organic Requisition Volume GrowthDiagnostic Lab Revenue per Requisition ChangeDiagnostic Lab Test Requisition VolumeDiagnostic Solutions Revenue
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare public companies
Compare 12.3% reported requisition growth with 3.4% organic growth and the 8.9-point gap.
Explore more topics in the Financial Research Encyclopedia.